BIOCON
|
The Current P/E Ratio of BIOCON is 68.95.
| Share Price | ₹393.3 | Jan 02,2026 |
| Market Cap | ₹52,577.5 Cr | |
| Earnings-TTM | ₹762.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 68.95x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of BIOCON
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹52,577.5 Cr] as on Jan 02,2026
(/) Earnings [ ₹762.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 68.95x ]
Thus, for BIOCON , the investors are currently willing to pay 68.95 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BIOCON !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BIOCON over the last five years.
Historical PE (Price/Earnings) ratio chart of BIOCON
PE Ratio Performance Analysis for BIOCON
- BIOCON 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 50.64x.
- BIOCON 's operated at median p/e ratio of 53.54x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BIOCON 's p/e ratio peaked in Mar2021 at 66.25x.
- BIOCON 's p/e ratio hit its five-year low in Mar2024 of 31.01x.
How does BIOCON 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| BIOCON | 762.50 | 68.95 | 52,577.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 39.45 | 414,929.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 68.27 | 169,644.0 |
| CIPLA LTD | 5,453.86 | 22.38 | 122,050.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 61.44 | 131,481.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.31 | 104,784.0 |
| MANKIND PHARMA LTD | 1,767.06 | 51.45 | 90,922.4 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 18.54 | 92,221.4 |
| LUPIN LTD | 4,347.53 | 22.13 | 96,195.0 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.46 | 70,547.1 |
| ABBOTT INDIA LTD | 1,508.95 | 39.57 | 59,713.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs BIOCON 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.31x |
| Max industry PE | 68.95x |
| Median industry PE | 39.45x |
| Average industry PE | 39.18x |
You may also like the below Video Courses